Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Epilepsy Behav. 2007 Nov;11(3):263-9.

Pharmacology of antiepileptic drugs during pregnancy and lactation.

Author information

  • 1Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA. page.pennell@emoryhealthcare.org

Abstract

Most women with epilepsy require continuous treatment during pregnancy, making antiepileptic drugs (AEDs) one of the most frequent chronic teratogen exposures. Therapeutic decisions should balance the risks to the developing fetus of AED exposure and of not treating or undertreating the epilepsy. The International AED Pharmacology Work Group of the Health Outcomes in Pregnancy and Epilepsy (HOPE) Forum identified four pharmacology topics critical to enhancing maternal and fetal outcomes for pregnancies exposed to AEDs: (1) hormonal therapies and endogenous changes: bidirectional interactions with AEDs; (2) pharmacokinetic alterations during pregnancy, the role of therapeutic drug monitoring, and the influence on seizure control and maternal and fetal outcomes; (3) multidrug transporters and their various roles during pregnancy; (4) breastfeeding in mothers taking AEDs. The report provides an overview of these key topics, highlights gaps in the current knowledge, and provides future directions for needed research.

PMID:
17996633
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk